Financial

  • Jun. 14, 2017 biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders

    VANCOUVER, BC–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) Dr. Mark Day, chief executive officer, has issued a message to shareholders detailing plans for the advancement of the Transcend Platform and the company’s in-house programs. To the Shareholders of biOasis Technologies Inc.: As the new CEO of biOasis, I am delighted to send my first message… Read more »

  • Apr. 24, 2017 BIOASIS ANNOUNCES GRANT OF STOCK OPTIONS AND RESTRICTED STOCK UNITS

    VANCOUVER, British Columbia–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that pursuant to the terms of its stock option plan (the “Option Plan”) and restricted stock units plan (the “RSU Plan”), the Company has granted a total of 2,377,478 stock options and 225,000 Restricted Share Units (RSUs) to its officers,… Read more »

  • Mar. 31, 2017 biOasis Announces Oversubscription of Financing

    VANCOUVER, British Columbia–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) is pleased to announce that further to its press release dated March 20, 2017, the Company’s non-brokered private placement (the “Private Placement”), is currently over-subscribed. As a result, subject to regulatory approval, the size of the Private Placement has been increased from up to… Read more »

  • Mar. 20, 2017 biOasis Announces Non-Brokered Private Placement

    VANCOUVER, British Columbia–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI) (the “Company”) announces a nonbrokered private placement of up to 4,500,000 units at a price of $0.70 per unit of gross proceeds of up to $3,150,000 (the “Offering”). Each unit will consist of one common share and one-half common share purchase warrant. Each whole warrant entitles… Read more »

  • Jan. 23, 2017 biOasis Provides AGM Update – Expanding The biOasis Deal Flow Pipeline

    VANCOUVER, British Columbia–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI), a pioneering biopharmaceutical company focused on the delivery of therapeutic drugs across the blood-brain barrier (BBB), has provided a corporate update in advance of its Annual and Special Meeting of Shareholders to be held at 1780 – 400 Burrard Street, Vancouver, BC, on January 23, 2017… Read more »

  • Dec. 22, 2016 biOasis Announces Adoption of Restricted Share Unit Plan

    VANCOUVER, BC–(Business Wire)– Bioasis Technologies, Inc. (OTCQB:BIOAF; TSX.V:BTI) (the “Company”) announces that subject to approval by the TSX Venture Exchange (“TSXV”) and ratification by the Company’s shareholders at the 2016 Annual and Special General Meeting of shareholders (the “AGM”), the Company adopted a restricted share unit plan (the “RSU Plan”). Further details regarding the RSU… Read more »

  • Apr. 8, 2016 biOasis Technologies Inc. Grants Stock Options

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V:BTI)(OTCQB: BIOAF)(the “Company”) announces that pursuant to the Company’s Incentive Stock Option Plan (the “Plan”), it has granted incentive stock options to directors, officers and consultants of the Company to purchase an aggregate of 1,950,000 common shares in the capital stock of the Company. The options are exercisable at… Read more »

  • Feb. 29, 2016 biOasis Announces Shares for Services Settlement

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQB: BIOAF)(the “Company”) wishes to announce its intention to issue 125,000 shares for services to a consultant of the Company that provides certain consulting services related to business development and financial advisory services. The issuance of shares for services will represent payment of consulting fees. The consulting agreement… Read more »

  • Sep. 29, 2015 biOasis Announces Listing on OTCQB Exchange

    Vancouver, BC–(Business Wire)– biOasis Technologies Inc. (TSX.V: BTI)(OTCQB: BIOAF)(the “Company”) wishes to announce that its current listing on the OTCQX will be changing to a listing on the OTCQB. The Company’s trading symbol will remain BIOAF. The Company remains in compliance with all relevant TSX Venture and OTCQB reporting standards and will continue trading on… Read more »

  • Sep. 5, 2014 biOasis Announces NSERC Grant to The University of British Columbia in Support of Collaborative R&D Work with biOasis

    Vancouver, British Columbia–(Business Wire)– biOasis Technologies, Inc. (OTCQX:BIOAF; TSXV:BTI), announces that the Natural Sciences and Engineering Research Council of Canada (“NSERC”) has awarded a grant to the University of British Columbia (“UBC”) in support of the university’s collaborative research and development programs with biOasis Technologies Inc. The University and biOasis continue to develop biOasis’ extensive… Read more »